Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.160.30ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.30NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.213ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.213ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.213ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.213NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.341ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.341ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.341ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.341NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.89ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.89ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.89ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.89NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.36.23ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.36.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.23NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.30ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.30ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.30NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.315ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.315ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.315ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.315NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.204ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.204ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.204ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.204NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.50ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.50ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.50ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.50NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.170ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.170ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.170ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.170NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.232ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.232ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.232ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.232NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.84ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.84ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.84ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used